(PharmaNewsWire.Com, April 05, 2017 ) According to the report Hormone Replacement Therapy Market, published by Market Data Forecast, the global market is projected to reach USD 22.31 billion by 2021, at a CAGR of 7.21% from 2016 to 2021.
Hormone replacement therapy (HRT) is employed in patients suffering from declining levels of hormones with the right administration of hormones into the body. These therapies are generally meted out to women undergoing menopause. Estrogen is among the most commonly administered hormones. However, progesterone and testosterone are also administered when needed.
Growing awareness on post-menopausal hazards, reimbursement policies, novel formulations, rise in unmet medical needs which require the employment of hormone therapy, benefits like lower risk of fractures are the few factors propelling the growth of global hormone replacement therapy market.
Responsible for more than half of the market revenues, the estrogen replacement therapy segment dominates the global HRT market. The largest consumers of estrogen replacement therapy are post-menopausal women.
North America dominated the market, where the majority of the contribution was from the USA owing to the well-established healthcare system. While the market in the APAC region is expected to witness a rapid growth during the forecast period.
Some of the key players operating in the hormone replacement industry are Abbott Laboratories, Novartis, Pfizer, Mylan Laboratories, Amgen, Merck & Co., Bayer, Eli Lily, Novo Nordisk, Wyeth, F. Hoffmann-La Roche, Hisamitsu Pharmaceutical Co. Inc.
About us: Market Data Forecast is a firm working in the areas of market research and business intelligence. We have rich experience in research across major industry segments like Healthcare, Agriculture, Food & Beverages etc. and we cater to the needs of both individual and corporate clients. Our research services contribute to key business areas like business process improvement, key decision making and developing an appropriate corporate strategy. We are truly committed to our clients and other stakeholders for providing customized research services of the highest quality all the while being an organization thats trusted for its integrity, respected for its accountability, and admired for its excellence, by both clients and competitors alike.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
